In summary, our study demonstrated that N-glycosylated LTβR inhibited the progression of HCC and increased sensitivity to the anticancer effects of glycolysis inhibitors by elevating the Th17/Treg cell ratio. This evidence concerns the gene LTBR and hepatocellular carcinoma.